Status: current, Primitive. Date: 31-Jul 2016. Module: SNOMED CT core
Descriptions:
| Id | Description | Lang | Type | Status | Case? | Module |
| 3304745011 | Blinatumomab (substance) | en | Fully specified name | Active | Case insensitive | SNOMED CT core |
| 3304746012 | Blinatumomab | en | Synonym | Active | Case insensitive | SNOMED CT core |
| Outbound Relationships | Type | Target | Active | Characteristic | Refinability | Group | Values |
| Blinatumomab | Is a | Monoclonal antibody | true | Inferred relationship | Some | ||
| Blinatumomab | Is a | Antineoplastic agent | true | Inferred relationship | Some |
| Inbound Relationships | Type | Active | Source | Characteristic | Refinability | Group |
| Blinatumomab-containing product | Has active ingredient | True | Blinatumomab | Inferred relationship | Some | 1 |
| Blinatumomab-containing product in parenteral dose form | Has active ingredient | True | Blinatumomab | Inferred relationship | Some | 1 |
| Blinatumomab only product | Has active ingredient | True | Blinatumomab | Inferred relationship | Some | 1 |
| Blinatumomab only product in parenteral dose form | Has active ingredient | True | Blinatumomab | Inferred relationship | Some | 1 |
| Blinatumomab 38.5 microgram powder for solution for infusion vial | Has precise active ingredient | True | Blinatumomab | Inferred relationship | Some | 1 |
| Blinatumomab 38.5 microgram powder for solution for infusion vial | Has BoSS | True | Blinatumomab | Inferred relationship | Some | 1 |
Reference Sets
Substance foundation reference set
FHIR